A Case of a Thoracic Arteriovenous Fistula Between an Intercostal Artery and a Pulmonary Vein.

Arteriovenous (AV) fistulas are irregular connections between arteries and veins, and thoracic AV fistulas are rarely identified in clinical practice. We report a case of a 56-year-old female with a history of esophageal adenocarcinoma treated with radiation and resection who presented to the hospital due to hemoptysis. She underwent bronchoscopy revealing a tracheobronchial fistula, and esophagogastroduodenoscopy revealing active arterial bleed. Subsequent angiography uncovered an AV fistula between her right T8 intercostal artery and pulmonary vein with a pseudoaneurysm. She underwent coiling of her T8 and T9 intercostal arteries with resolution of her symptoms.

Touch-up and recurrence rates after voltage mapping for verification of pulmonary vein isolation following cryoablation of paroxysmal atrial fibrillation.

PURPOSE: The procedural endpoint following cryoballoon ablation (CA) for paroxysmal atrial fibrillation (PAF) is pulmonary vein isolation (PVI), which is typically confirmed by entrance/exit block using a circular mapping catheter. The present study added an assessment of ablation gaps with high-density voltage mapping after standard confirmation of PVI. Relationships between the need for touch-up ablation, patient characteristics, and atrial arrhythmia recurrence were explored. METHODS: PAF patients received CA through standard of care treatment, with PVI assessed by bidirectional block confirmation, followed by voltage mapping. Radiofrequency ablation was performed as needed for voltage breakthrough and or additional rhythms. Freedom from atrial arrhythmia recurrence through 12-month follow-up was analyzed retrospectively with statistical survival models. RESULTS: A total of 77 PAF patients (age 66.1 ± 11.6, CHADS2 1.8 ± 1.0) were followed for 1.2 ± 0.3 years after CA. During the index procedure, pulmonary vein (PV) touch-up was required in 59 patients (76.6%) and ablation of additional atrial fibrillation targets beyond PV was required in 26 patients (33.8%). Kaplan-Meier estimates of freedom from atrial arrhythmia recurrence at 1 year were 62 ± 6%. Rates were lower for patients requiring touch-up ablation (58 ± 6% vs. 78 ± 10%) or with CHADS2 scores > 2 (33 ± 12% vs. 69 ± 6%). Cox regression models showed that the need for touch-up ablation increased recurrence (p = .045, HR = 2.6) after adjusting for hypertension and heart failure. CONCLUSION: The high rate of PV touch-up suggests that initial CA lesions may be less durable than previously assumed, while the higher recurrence rate in patients requiring touch-up may indicate that additional factors make these patients more difficult to treat.